Everest Medicines wins China approval for CARDAMYST in acute PSVT

Everest Medicines has received approval from China’s National Medical Products Administration for CARDAMYST, or et...

September 7, 2026 | Monday | News
CMS wins China approval for Lumirix in mild-to-moderate atopic dermatitis

China Medical System Holdings has announced that its subsidiary Dermavon Holdings has received approval from China&rsquo...

September 7, 2026 | Monday | News
PolyU and Diagens Tech establish joint lab to advance AI-driven medical innovation in Hong Kong

The Hong Kong Polytechnic University (PolyU) and Hangzhou Diagens Biotechnology Co (Diagens Tech) have officially establ...

September 7, 2026 | Monday | News
Everest Medicines’ LEROCHOL BLA accepted in China for hypercholesterolemia

Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...

September 7, 2026 | Monday | News
China's Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy

Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...

September 4, 2026 | Friday | News
China's Biocytogen teams up with Qilu Pharma to support drug development in neuroscience

Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...

September 3, 2026 | Thursday | News
Ascletis doses first participant in global Phase III trial of oral GLP-1 candidate ASC30

Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investig...

September 2, 2026 | Wednesday | News
Medtronic inks $700 M partnership deal with Hong Kong's Cornerstone Robotics

Medtronic, a global leader in healthcare technology, has announced a strategic partnership with Hong Kong based startup ...

September 1, 2026 | Tuesday | News
China's Simcere Zaiming signs $1.5 B deal with Roche for SIM0660 global development

Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...

September 2, 2026 | Wednesday | News
DualityBio and Genentech partner on next-generation ADCs in deal worth over $1 billion

Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...

August 31, 2026 | Monday | News
CanSinoBIO accelerates overseas growth as vaccine portfolio and mRNA pipeline expand

CanSino Biologics reported continued momentum in its international business during the first half of 2026, alongside pro...

August 31, 2026 | Monday | News
Fosun Pharma strengthens innovation pipeline as Henlius and global drug portfolio expand

Fosun Pharma continued to strengthen its innovation-led growth strategy in the first half of 2026, supported by increasi...

August 31, 2026 | Monday | News
Alebund advances renal pipeline as AP301 enters China regulatory review

Alebund Pharmaceuticals has reported progress across its renal disease portfolio, including completion of enrolment in a...

August 28, 2026 | Friday | News
AUScelerate and Shanghai Center of Biomedicine Development sign MoU to advance life sciences innovation

AUScelerate and the Shanghai Center of Biomedicine Development have signed a Memorandum of Understanding (MoU) to build ...

August 28, 2026 | Friday | News
China's Dual-Track AI Strategy: Strengthening Regulation While Accelerating Life Sciences Innovation

The global AI debate is often framed as a choice between acceleration and restraint: innovate first and regulate later, ...

September 1, 2026 | Tuesday | Opinion
PolyU and University of Oxford forge strategic partnerships to advance academic collaboration

The Hong Kong Polytechnic University (PolyU) and the University of Oxford, UK have signed a Memorandum of Understanding ...

August 27, 2026 | Thursday | News
China's Haisco Pharma enters into agreement worth $1.5 B with US-based Sentivera

Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture found...

August 26, 2026 | Wednesday | News
WHO and Peking University strengthen collaboration to advance health emergency preparedness

The World Health Organization (WHO) and China's Peking University have entered into a two-year project collaboration agr...

August 25, 2026 | Tuesday | News
Akeso receives China clinical trial clearance for B7-H3 ADC AK157D1

Akeso has received clinical trial clearance from China’s Center for Drug Evaluation for AK157D1, a next-generation...

August 24, 2026 | Monday | News
Leads Biolabs’ opamtistomig NDA accepted in China for neuroendocrine carcinoma

Nanjing Leads Biolabs has announced that China’s Center for Drug Evaluation has accepted the New Drug Application ...

August 24, 2026 | Monday | News
CureGene doses first participant in Phase I trial of liver-targeting CG-0416

CureGene has dosed the first participant in an Australian Phase I clinical trial of CG-0416, an investigational oral liv...

August 24, 2026 | Monday | News
CStone secures China IND approval for EGFR/HER3 bispecific ADC CS5007

CStone Pharmaceuticals has received approval from China’s National Medical Products Administration to initiate cli...

August 24, 2026 | Monday | News
China Biotech’s Global Breakout: Innovation, Deals and the Next Investment Cycle

China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing de...

August 24, 2026 | Monday | Influencers
Hong Kong Applied Science and Technology Research Institute advances AI-enabled biomaterials and digital health innovation

The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU), US have sign...

August 24, 2026 | Monday | News
Brii Biosciences advances mRNA cancer vaccine into clinical evaluation for liver cancer

Brii Biosciences has advanced its internally developed mRNA therapeutic cancer vaccine BRII-5395 into clinical evaluatio...

August 21, 2026 | Friday | News